GB2079610A - Body-implantable electromedical apparatus - Google Patents
Body-implantable electromedical apparatus Download PDFInfo
- Publication number
- GB2079610A GB2079610A GB8127414A GB8127414A GB2079610A GB 2079610 A GB2079610 A GB 2079610A GB 8127414 A GB8127414 A GB 8127414A GB 8127414 A GB8127414 A GB 8127414A GB 2079610 A GB2079610 A GB 2079610A
- Authority
- GB
- United Kingdom
- Prior art keywords
- microprocessor
- patient
- memory
- heart
- pacemaker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communication system, e.g. handshaking, transmitting specific data or segmenting data
- A61N1/37264—Changing the program; Upgrading firmware
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Electrotherapy Devices (AREA)
- Analogue/Digital Conversion (AREA)
Abstract
A cardiac pacemaker includes a microprocessor 300 and a memory 302 capable of being programmed with a variety of processes for stimulating a heart and/of sensing and transmitting to an external device conditions of the heart or pacemaker. The microprocessor controls a multiplexer 306 to input signals from atrial and ventricular leads, the power source or a reed switch operable by an external magnet, on lines 338 a-f. The output comprises decoder 342 and latch 340 with output select switches 330 which are selectively operable to supply stimulation pulses to the leads or allow sensing. External apparatus 343 may transmit coded information to change the stored program or operation of the reed switch may select a different program starting address. The microprocessor 300 includes an address counter 307, and an auto reset oscillator circuit 344 periodically (e.g. every 0.5s) applies a reset signal to reset the address to the program starting address whereby if a noise signal (eg. from a defrillation pulse) causes an erroneous or meaningless memory location to be addressed the program will not 'hang up'. Reset circuit 344 is defeated during normal operation by a signal on line 346. <IMAGE>
Description
1 Body-lniplantable electromedical apparatus GB 2 079 610 A 1 This
invention relates to body-implantable electromedical apparatus such as internally implanted electronic devices adapted to be operated in a variety of modes for stimulating body tissue orto monitor various conditions of the device itself or of body tissue, e.g., the patient's heart.
Heart pacers such as that described in our U.S.
Patent No. 3,057,356 are known for providing electrical stimulus to the heart whereby it is contracted at a desired rate in the order of 72 beats per minute. Such a heart pacemaker is capable of being implanted within the human body and operative in such an environment for long periods of time. Typically, such pacemakers are implanted in the pectorial region or in the abdominal region of the patient by a surgical procedure, whereby an incision is made in such region and the pacemaker with its own internal power supply, is inserted within the patient's body. This pacer operates asynchronously to provide fixed-rate stimulation not automatically changed in accordance with the body's needs, and has proven effective in alleviating the symptoms of complete heart block. An asynchronous pacer, however, has the possible disadvantage of competing witlithe natural, physiological pacemaker during episodes of normal sinus condition.
An artificial pacer of the demand type has been developed wherein the artificial stimuli are initiated only when required and subsequently can be eliminated vilien the heart returns to the sinus rhythm. Such a demand pacer is shown in U.S. Patent No. 3,478,746 issued November 18, 1969 and entitled 35---CARDIACIMPLANTABLE DEMAND PACEMAKER". The demand pacer solves the problem arising in asynchronous pacers by inhibiting itself in the presence of ventricular activity (the ventricle's R wave), but by coming "on line- and filling in rn-issed-heart- beats in the absence of ventricular activity.
A problem with such prior art, implantable demand pacers is that there was no way to ternporarily increase or decrease the rate or other operating parameter at which these stimulating pulses are generated without surgical intervention. Still another problenn is the great difficulty in establishing the battery life remaining, in detecting and correcting a failing electrode, and in establishing an adequate R-wave sensitivity safety marghnin an implanted demand pacer.
Son L. irnplantable cardiac pacers presently conscructed have a rate overdrive capability but do not adequately cheek the viability of the demand func'don. Other devices are provided with a magnetic r, 5 reed syiitch arrangernrent which can deactivate 'the demand amplifierforihe purpose of checking u'le deiriand.i'uriction but are lacking in a rate overdrive capability.
[Anoiier in, proverrientirf hich has occurred since G reatbatch first disclosedthe implantable cardiac Pacei-iialcc-r is rneansto aiio,,sjthe pacema-kerto'be reprograrnmed aficer it has been implanted. In United States Patent 3,805,793 in the name of Reese Terry, Jr. et a[, entitled "Implantable Cardiac Pacer Having Adjustable Operating Parameters", which issued in 1974, circuitry is disclosed to allowthe rate of the pacemakerto be noninvasively changed after it has been implanted. The rate varies in response to the number of times a magnetically operable reed switch is closed. The Terry et al device operates by counting the number of times the reed switch is closed and storing that count in a binary counter. Each stage of the counter is connected to either engage or bypass one resistor in a serially connected resistor chain, which chain is apart of the FIC time constant controlling the pacemaker rate.
The concept of the Terry et al device has been improved upon by the apparatus shown in United States Patent 4,066,086 in the name of John M.
Adams et al, entitled "Programmable Body Stimulator", which issued in 1978, and which discloses a programmable cardiac pacemaker that responds to the application of radio frequency (RF) pulse bursts while a magnetic field held in close pro- ximity to a magnetically operated reed switch included within the pacemaker package holds the reed switch closed. In the Adams et al circuit, again onlythe rate is programmable in response to the number of RF pulse bursts applied. The use of radio frequency signals to program cardiac pacemakers was earlier disclosed by Wingrove in the United States Patent 3,933,005 entitled "Compared Count Digitally Controlled Pacemaker" which issued in 1974. The Wingrove device was capable of having both the rate and pulse width programmed. However, no pacemaker has ever been described which is capable of having more than two parameters programmed or selected features or tests programmed on command. Such a pacemaker could be cal- 10() led a universally programmable pacemaker.
One area where cardiac pacing technology has lagged behind conventional state of electronic technology involves utilization of digital electrical circuits. One reason for this has been the high energy required to operate digital circuits. However, with more recent technology advances in complementary metal oxide semiconductor (CMOS) devices fabricated on large scale integrated circuits, together with the improvements of cardiac pacemaker batteries, digital electronic circuits are beginning to be utilized in commercial pacemakers. The inherent advantages of digital circuits are their accuracy, and reliability. Typically, the digital circuit is operated in response to a crystal oscillator which provides a very stable frequency over extended periods of time. There have been suggestions in the prior art for utilizing digital techniques in cardiac stimulators and pacemakers since at least 1966. For instance, see the article by Leo F. Walsh and Emil Moore, entitled "Digital Tim- ing Unit for Programming Biological Stimulators" in The American Joumal of MedicalElectronics, First Quarter, 1977, Pages 29 through 34. The first patent suggesting digital techniques is United States Patent 3,557, 796 in the name of John W. Keller, Jr., et al, 12.5 and is entitled "Digital Counter Driven Pacer", which issued in 1971. This patent discloses an oscillator This speciuication as filed includes a corn puter pro, -gram which is not here reproduced.
2 GB 2 079 610 A 2 driving a binary counter. When the counter reaches a certain count, a signal is provided which causes a cardiac stimulator pulse to be provided. Atthe same time the counter is reset and again begins counting the oscillator pulses. Additionally, in the Keller et al patent, there is disclosed the digital demand con cept, in which the counter is reset upon the sensing of a natural heartbeat, and the digital refractory con cept, in which the output is inhibited for any certain time after the provision of a cardiac stimulating 75 pulse orthe sensing of a natural beat.
As mentioned above, digital programming techni ques are shown in both the Terry et al patent 3,805,796 and the Wingrove patent 3,833,005. Wing rove additionally discloses digital control circuitry for controlling the rate of the stimulating pulses by providing a resettable counter to continually count up to a certain value that is compared against a value programmed into a storage register. The Wingrove patent also shows provisions for adjusting the out put pulse width by switching the resistance in the RC circuit which controls the pulse width.
Other patents disclosing digital techniques useful in cardiac pacing include United States Patents 3,631,860 in the name of Micheal Lopin entitled "Var iable Rate Pacemaker, Counter-Controlled, Variable Rate Pacer"; 3,857,399 in the name of Fred Zacouto entitled "Heart Pacer"; 3,865,119 in the name of Bengt Svensson and Gunnar Wallin entitled "Heart beatAccentuated with Controlled Pulse Amplitude"; 3,631,860 in the name of Michael Lopin entitled "Var "Demand Pacer"; 4,038,991 in the name of Robert A.
Walters entitled "Cardiac Pacer with Rate Limiting Means"; 4,043,347 in the name of Alexis M. Renirie entitled "Multiple-Function Demand Pacer with Low Current Drain"; 4,049,003 in the name of Robert A.
Walters et a[ entitled "Digital Cardiac Pacer"; and 4,049,004 in the name of Robert A. Walters entitled "Implantable Digital Cardiac Pacer Having Externally Selectable Operating Parameters and One Shot Digi tal Pulse Generator for Use Therein".
Though it has been suggested that various para meters, i.e., pulse width and rate, may be changed within an internally implanted pacer, it is desired to provide a device that is capable of operating in vari ous, different pacing and/or sensing modes. The sys tems of the prior art are capable of storing by means of digital counter circuitry a programmable word indicative of desired rate or pulse width. In an inter nally implanted device, the space to incorporate a plurality of such counters whereby a number of such functions could be programmed, is indeed limited.
Further, there are considerations of the available energy to energize such counters, as well as of the life of its internal power source as a result of the imposed drain. It is well recognized in the art that the complexity of the circuit incorporated within an internally implanted device is limited by many fac tors including the drain imposed upon the battery and therefore the expected life of a battery before a surgical procedure is required to replace the device's power source, e.g., a battery.
We have proposed a body-implantable electrical stimulating and sensing apparatus comprising con trol means including a control processor and memory means, the control processor having address means for addressing a program stored within a selected storage portion of the memory means and the memory means having at least first and second storage portions for storing different first and second programs respectively, first and second select switch means arranged to be controlled by the processor and connected respectively to first and second lead means, which lead means are arranged to provide stimulating signals to body tissue andlor supply sensed signals to the control means, and means for selectively changing the address of said address means, whereby said address means applies a starting address to one of said first and
Claims (3)
1 9 GB 2 079 610 A 9 Memory Symbolic Memory Step Address Notations Contents Remarks Location (Hexadecimal) (Hexadecimal) 00 0000 D = 00 200 01 LDI F8 202 02 00 00 202 03 PHI,3 B3 202 04 PLO, 3 A3 Set LC=0 202 GLO, 3 83 R(3)--->D 204 06 BNZ 3A Is LC=00 204 07 OUTPUT 3D No? Go to 204 OUTPUT State Memory Address 3D 08 LDI F8 YES? SET 206 OUTPUT State Tableto AddressAO 09 OP AO R(A) = QP 206 OA PLO, A AA 206 OB LDI F8 SET 206 0C TP A4 R(B)=TP 206 OD PLO, B AB 206 OE LDI F8 206 OF VP BO 206 PLO, C AC Set R(C) 206 =VP 11 LDI 206 206 F8 13 PLO, D AD Set R(D) 206 12 TR A3 =TR 14 LDI F8 206 VDD B6 206 16 PLO, E AE Set R(E) 206 =VDD 17 SEX, E EE SetX=E 208 18 INP 68 READ A-D 208 11 (VDD) 19 SEX, A EA SetX=A 210 1A OUT 60 M(QP)--)OUT, 210 PQ+1 1B INC B 1 B TP + 2 214 1C INC B 1 B 214 1D LDA, C 4C M(R(C))--D, 214 VP + 1 1E SEX, E EE E -X 212 1 F SM F7 VP-VDD 212 BDF 33 If DF=1 212 VP:-5VDD 21 VPVDDCom- 1B BRANCH to 214 pare VPVDD Compare 22 DEC B 2B DECREMENT 212,214 R(B) 23 DEC B 2B DECREMENT 212,214 R(C) BY2 24 DEC C 2C 212,214 BY1 LDI F8 1 216 26 03 03 216 27 PLO, 3 A3 SET LC=3 216 28 STROBE A-D 62(15) 218 GB 2 079 610 A 10 29 LDA, D 4D M(TR)--->D, 220 TR + 1 2A PLO, 4 A4 M(TR)-TC 220 213 DEC, 4 24 TC-1 238 2C GLO, 4 84 2D BNZ 3A TESTTC=O 224 2E TEST 2 32 No. to test 224 LC = 2 2F DEC, 3 23 Yes, LC-1 232 BR 30 232 31 CHECKO 05 232 (LC = 0) 32 GLO, 3 83 R(3)-D 226 33 XRI F13 226 34 02 02 Is LC=2 226 BNZ 3A 226 36 DECTC 213 LC=2, 226 BRANCH 37 BN1 3C TEST R-Wave 228 INPUT 38 DECTC 213 No R-Wave 228 INPUTBRANCH 39 B2 35 TEST REED 230 SWITCH 3A DECTC 213 YES to DECRE- 230 MENTTC 313 BR 30 No REED 230 SWITCH 3C STRT-1 01 BRANCH to STRT-1 3D SEX, A EA SETX=A,QP 234 3E OUT 60 M(QP)-OUT' 234 QP + 1 3F LDA 413 236 PLO, 4 A4 M(TP)-TC,
236 TP + 1 41 BR 30 BRANCHTO 222 42 DECTC 213 DECREMENT 222 TC Commentl Machine Assembly Language Address Comment Language Code AO QP Q REF 01 Al QPP 02 A2 P PW 04 A3 TR T REF FIF A4 TP SP 5.2V 60 A5 PW 5.2V 03 A6 SP 4.8V 60 A7 PW 4.8V 06 A8 SP 4.4V 60 A9 PW4.4V 08 AA SP4V 60 AB PW 4V 10 AC SP 3.6V 60 AD AE SPOV 60 AF PW OV 12 BO VP V5.2 52 Bi V4.8 48 B2 V4.4 44 B3 V4.0 40 SP Sense Period B4 V3.6 36 PW = Pulse Width B5 VO.0 00 B6 VDD 11 GB 2 079 610 A 11 which is reproduced below as follows:
V1 V2 V3 V4 V5 V6 HEX B3 179 = 5.2 V A2 162 = 4.8 V 91 145 = 4.4 V 128 = 4.0 V 6E 110 =3.6 V 00 = 0.0 V The next set of values of the sense time and the pulse width are obtained from the time duration table which is set out below:
T21 T31 T22 T32 T23 T33 T24 T34 In Figure 5, there is shown a flowchart of the steps representing the instructions listed above, the corresponding step for its instructions being identified under the heading "Step Location---. The program begins atthe start step 200, transferring to step 202 wherein the loop counter LC formed by the register 11(3), is setto zero as implemented by the instruction stored at the memory address 04, as shown above.
As shown in Figure 4A, the demand ventricular pac ing mode includes a refractory state corresponding to the refractory period, during which the ventricular amplifier 139 is clamped, a sensing period state dur ing which the electrical activity of the ventricles is accessed and sensed, and a pulse width state during f5 which the ventricular stimulating pulse is applied to 80 the patient's ventricle 42. As will be evident from a further description of the steps of the program, the program proceeds in loop fashion through the steps of Figure 5 three times, one for each of the three mentioned states, with the loop counter LC being decremented upon completion of each loop to indi cate that the process has moved to the next state.
Initially, the loop counter LC is setIto zero in step 204. The process now moves to step 206, wherein the pointers VP, QP, TP and TR as defined above are 90 initialized to their starting points. For example, VP, as defined above, is the voltage transition table pointer. Thus, in step 206, the register R(C) is set to the first location within the transition point table, which defines the voltages with which the output voltage V, of the power source 126 is to be corn pared. The pointer QP pointing to the output state table as stored in register R(A), points to that loca tion within the output state table identifying which of the states as shown in Figure 4a, the processor is, i.e., within either of the refractory period, the sensing or partial period orthe pulsing or pulse width period.
The output state table is reproduced below as fol lows:
Q11 01 Q21 02 Q31 04 Refractory State Sense State Pulse Width State Next, instep 208, the microprocessor 100 commands the AID converter 108 to read out a digital indication of the power source voltage V.. In step 210, the output state QP as stored within the microprocessor register R(A) is incremented by one, i.e., to move it to the next output state. Thus, at this point, the register R(A) indicates that the process is in the initial refractory period. Next, in step 212, the voltage V. is compared with the transition point voltage (VP) as pointed to by the voltage transition point table pointer VP as stored in register R(C). If the voltage V. is greater than the voltage transition point, the process moves to step 216; if not, the process moves to step 214, wherein the voltage transition point table pointer VP is incremented one to point to the next location therein to obtain the next lower value of the transition point voltage and further the time duration table pointer TP is incremented by two to designate the next two locations within the time duration table. The next value of the voltage transition point is obtained from the voltage transition point table, 475 ms V, z--- 5.2V 800 gs 475 ms 100Ogs J V, t 4.8V 475 ms V, t 4AV 1250 gs 475 ms 1550 gs T25 T35 T26 T36 V, t 4.OV 1850jus 600 ms V, t 3.8V 600 ms 2300 gs V,: 3.6V As seen in each two locations there is given first a duration for the sense period and then the pulse width fora given voltage transition point, i.e., a reference value with which the voltage Vs is to be compared. Thus, as will be explained, the program adjusts the pulse width of the ventricular stimulating pulse to maintain constant energy within the ventricu lar stimu lating pu Ise, as well as to increase the sense period abruptly, as the voltage V, of the power source 122 attenuates, to provide a step rate slow down performance at end of battery life.
In step 214, the voltage transition point is moved from V1 to V2, e.g., from 5.2 to 4.8 volts. Again, the value of V, is compared with the voltage transition point (VP) and if greater (yes), the program moves to step 216 wherein the value of the loop counter LC is loaded with the value "three" indicating thatthe oscillator is in the refractory period. Thereafter, the A/D converter 108 is strobed to read out the power source voltage V,. In step 220, the value TR of the refractory period stored at location TR is read out and stored in the time counterTC (register R(4)).
12 GB 2 079 610 A 12 Thereafter, the process moves to step 222, wherein the value stored in the time counter (TC) is decremented by one and the timing of a period is initiated to cycle through step 222 until the value stored in the time counter (TC) is counted down to zero. Next, in step 224, a decision is made whether the value of the time counter TC equals zero, i.e., its timing function has been completed, and if not, the process moves to step 226, where a decision is made to determine whether the loop counter LC equals to 2 indicating whether the process is in the sense state corresponding to the RV sensing period; if not, which is the case atthe present point, the process loops through steps 222,224,226 until the initial count (corresponding to the refractory period) as set in the time counter TC has been decremented by step 222 to zero, as detected by step 224, thus terminating the refractory period. At that point, step 224 moves the process to step 232, wherein the loop counter LC is decremented by one, to thereby indicate that the process is in the sense state, i.e., LC equals 2, whereby the process returns to step 204. At this point, the loop counter LC does not equal to zero and the process moves to step 234, wherein the out- put state table pointer QP is incremented by one, whereat at this point in time, the process is moved to the sense state. Next in step 236, the value obtained from the time duration table is placed into the time counter TC, and the time duration table pointer (TP) is incremented by one to address the next wider pulse width within the time duration table.
Thereafter, the process moves via step 222 to decrement byone the count loaded into the time counterTC and if not zero as decided by step 224, the program advances to step 226 and if in the sense state, which the process is at this instance, the process moves to decision step 228 to determine whether an R wave has been applied to the multiplexer 106. If within the time period of a single decre- ment count, the R wave is not sensed, the process moves back to cycle to again, decrementing in step 222 the count corresponding to the sense period until the count equals zero as detected by step 224. If an R wave is detected by step 228, the process moves to step 230 to check the status of the reed switch 23 and if open, the process is reset as indicated in Figure 4Ato return the process to to, i.e., to step 202 whereatthe loop counter LC is reset tozero and the process is reinitialized. The reed switch 23 is a magnetically actuable switch within the pacemaker 12. After implantation, the physician may actuate the reed switch 23 by placing an external magnetic field close to the implanted pacemaker 12 whereby the reed switch 23 is closed to initiate the asynchronous mode of operation. If the reed switch 23 is closed indicating a desire to operate in the asynchronous mode, the process continues to loop, returning to step 222 to again decrementthe time count TC, even if an R wave is detected. In this manner, the detection of an R wave is ignored and the pacemaker 12 proceeds to pace in the asynchronous mode of operation, without resetting upon detection of the R wave.
After the second sensing period has timed out, i.e., when the count stored in the time counter TC has counted down to zero as indicated by step 224, the process is again transferred to step 232 wherein the loop counter LC is decremented byone, wherein the value stored therein equals one indicating that the process is going into its third loop and is returning to step 204. Since the loop counter LC does not equal zero, the process transfers to step 234, whereby the value QP of the output state is incremented by one indicating that the process is now in the pulse width state. Next, in step 236, the value of the time duration is addressed and accessed from the time duration table and is stored in the time counter TC. The value of the time duration table pointerTP is incremented by one to point to the next location within the time duration table as set out above. At this point, the process enters into a series of cycles whereby the count within the time counterTC is decremented by one by step 222, and if not zero transfers to step 226 and not being in the sensing period, returns to be again decremented in step 222. The process repeats until the value of the count in the time counter TC has been decremented to zero as decided by step 224. At this time, the process again moves to step 232 wherein the loop counter LC is again decremented by one, the value now being zero. The process moves to step 204 and the process begins all over again with the initialization of the values of VIP, QP, TP and TR by step 206.
In the above, there has been described the manner in which the pacemaker 12 implements the program forthe demand ventricular mode as stored in the memory 102, moving first to the refractory period, then to the sense period and finally to the pacing or pulse width period before again beginning a new cycle. As indicated above, the length of each of the refractory and pulse width periods is determined by the voltage V. of the power source 226, with the aforementioned periods and in particular the pulse width period increasing as the voltage V. decreases in orderto maintain substantially constant the energy content of the ventricular stimulating pulse.
As explained, above, the memory 102 may be programmed with any of a plurality of modes of operation for pacing the patient s heart, selectably dependent upon the patient's condition, even a change of condition afterthe implantation of the heart pacemaker 12. For example as shown in Figure 4B, the pacemaker 12 maybe operated in an A-V; sequential timing mode, wherein stimulating pulses are apiplied to each of the patient's ventricle 42 andz atrium 40; after corresponding refractory periods the activity of the ventricle is sensed and if a ventricular signal does occur after eitherthe stimulation of the ventricle or the atrium, the pacer is reset. The output and input connections of the pacemaker 12 shown in Figure 2, are selected as shown in Figure 3B. With respectto Figures 313 and 4B, the patient's ventricle 47 is pulsed immediately before time to by applying a stim ulus signal via the lead 19. After to, the ventricu- tar sensing amplifier 139 is clamped by the application of the signal TC1 to the select switch 130c, whereby the input of the amplifier 139 is connected to ground for a first refractory period from to to t, Also during the first refractory period, the ventricular output capacitor Cv is recharged by applying the con- J.
13 GB 2 079 610 A 13 5( troi signal TcJothe select switch 130a,wherebythe power source voltage V. is applied to charge the capacitor Cv. In the period t, to t2, a control or timing signal t,, as derived from the microprocessor 100 is applied to close the switch 1OW, whereby a ven tricular R wave, if present, is applied via the ventricu lar amplifier 139 and the multiplexer 106 to resetthe timing operations of the microprocessor 100.
If att2no ventricular R wave has been sensed, the pacemaker 12 causes a stimulating puiseto be applied via the lead 17 to the patient's atrium 40. In particular, a pulse control signal Tw, is applied via the driver amplifier 134b and resistor RA, to the base of the output atrial transistor GA, rendering the trans istor QA conductive causing a discharge of the output atrial capacitor CA into and thereby stimulating the patient's atrium 40. Beginning attime t,, the timing control signal is applied to select switch 130c, clamp ing the input of the ventricular amplifier 139 to ground, whereby any signal in response to the 85 stimulation of the atrium is disregarded. Beginning attime t,, the atrial output capacitor CA is recharged by the application of the timing control signal TAto close the select switch 130b to apply the power source voltage V,, to the capacitor CA. In the period from 'E4tO t., again the activity of the ventricle is sensed and a timing control signal from the microp rocessor 100 applied to close switch 106a'permitting the ventricular R wave to be applied via the unclarnped, ventricular amplifier 139 and the closed stAtch 106a'to the microprocessor 100. If the ven tricular R wave is sensed during this second sensing period from t, to t,, the timing period is reset to to. If no R wave appears in the period frorn t4 to t5, a firri ing pulse V is applied from the microprocessor 100 via the ventricular driver 134a and the resistor R,, to render conductive the ventricular output transistor Qv, whereby the charged capacitor Cv is coupled to ground discharging the capacitor Cv and applying via the lead 19 a sttimulating pulse to the patient's ven-1 ricle 42. Typical values for the periods TA extending from TO to T2 and for the period TV from TO to T5 are provided below:
TV(MS) 2000 1000 850 850 750 750 650 550 TAWS) 1700 750 700 650 600 500 300 425 The A-V sequential method of operation as shown in Figure 413 may be programmed illustratively in a manner similar to that shown in Figure 5, except that the six output states and their corresponding time periods as shown in Figure 4B, are set by counter values as derived from a corresponding table stored in the memory 102. Thus initially, typical values of TV and TA are programmed for a particular patient by accessing particular locations within the corresponding tables, one for each of the six periods, After a count has been entered into the time counter, successive cycles are carried out until the count is counted down to zero to time outtliat period.
In Figure 4C, there is illustrated the timing diagram of an atrial synchronous ventricular inhibited pacemaker (ASVIP), wherein each of the ventricular and atrial activity of the patient's heart is sensed to reset the timing period. Such a mode of operation is typically used in a younger patient whose atria are beating in a normal fashion but whose ventricles may or may not be defective. It is desired to speed up the beating of the atria and to stimulate thereby the ventricular activity. A sensed atrial P wave initiates a timing cycle; however if there is a failure in the conduction of this signal to the patient's ventri- cle, a stimulating signal will in any case be applied to the patient's ventricle 42. It is desired to utilize the rate of the beating atria to synchronize the ventricular pacing which may be impaired because of a myocardial infarction or otherwise defective cardiac conduction system. As shown in Figure 4C, the cycle begins attime to with the sensing of the atrial P wave. As shown in Figure 4C, a single cycle is divided into six timing periods (and states). During the firsttiming period from to to t, (as well as the second and third timing periods to time t,) the atrial amplifier 141 is clamped to ground by a timing signal applied to close the switch 130d. Also in the initial period the unclamped ventricular sense amplifier 139 applies any R wave signal applied from the ventricle 42 via the lead 19 to a switch 106al, which is closed by an RV control signal. If during the initial period from t,, to t,, an R wave signal is sensed, the timing cycle is reset to t, In the second or pulsing period from t, tot, the atrial amplifier 141 remains clamped to ground, the switch 130d being closed, and a timing con, rol pulse T is applied via the driver amplifier 134a and the resistor R,, to the base of the ventricular output transistor Qv, whereby the previously charged ventricular output capacitor Cv discharges through transistor Qv via the lead 19 to the patient's ventricle 42. Also during the second period (also extending into periods three and four to timetIthe ventricular amplifier 139 is clamped to ground by a switch 130c to which is applied a clamp ventricular signal TC1, whereby heart activity as would appear in the post-ventricular stimulating period is ignored. In the fourth and fifth periods from t3 to t5, the atrial amplifier 141 is unclamped permitting the atrial P wave signal tobe applied thereby via a closed select switch 106Wto reset the timing process to to. From t3 to t5, a sense timing signal RA is applied to close the switch 106K In normal operation, it is contemplated that an atrial P wave signal may be sensed during the fourth and fifth timinq periods from t, to t,, whereby the timing cycle is reset to zero. If however no P wave is sensed, the ventricle is again stimulated by the application of a control pulse Tw,to the base of the ventricular output transistor Qvwhereby a pulse is applied via the lead 19 to the patient's ventricle 42, as explained above.
The ASVP method of pacing may be programmed illustratively in a manner similar to that shown with respect to Figure 5 with six periods or output states defined in a similar manner and with each of the six 14 GB 2 079 610 A 14 timing periods established by addressing or establishing pointers to corresponding tables, whereby varying values of the periods are sent into a timing counterto be decremented as the process is execuated through each of six loops.
Referring now to Figure 6, there is shown an alternative embodiment of the adaptable programmable pacemaker of this invention, wherein similar elements and circuits are identified with similar num- bers to that shown in Figure 2, except being numbered in the 300 series. For example, the microprocessor or CPU is identified by numeral 300 and is coupled to a multiplexer 306, whereby a selected one of the inputs 338a, b, e or f is applied in the form of a flag via bus 318 to the microprocessor 300. The microprocessor selectively addresses via address bus 312 a memory 302 having illustratively a plurality of sections 302-1 to 302-16. As shown in Figure 6, the memory 302 may take the form of a volatile memory such as a random access memory, or a programmable read only memory (PROM) or an erasable read only memory (EROM). The addressed data is read out from the memory 302 and applied to a data bus 310 interconnecting the memory 302, the microprocessor 300, a decoder 342 and an AID converter 308. The A/D converter 308 converts the analog value of the supply voltage V. to a digital form to be input to the microprocessor 300 via data bus 310. It is understood that the other analog val- ues, such as the P and R waves are also converted to digital form and scaled before application to the multiplexer 306; the AID converter and the scaler circuit, as would be coupled to the multiplexer 306, are similarto that described above and are not shown in Figure 6. The microprocessor 300 applies timing signals via an N bus 352 to command the decoderto initiate decoding of the signals appearing upon the data bus 310. The decoder 342 interprets the output of the microprocessor 300 to select one of a plurality of switches 1 to 16 within the block 330. In this regard each such switch of the block 330 has its own latch within block 340 that is set by the output of the decoder 342 and in turn is coupled to an amplifier and output drive circuit as described above. In this manner, flexibility is assured to provide a plurality of output circuits which may be coupled by leads to various portions of the patient s heart, as well as to assure the ability to recharge the output drive circuits and to be able to access data at various points either on the patient s heart or on other parts of the patient's body. Thus a telemetry system is provided for transmitting data from or to the programmable pacemaker as shown in Figure 6.
In accordance with the invention, an auto-reset oscillating circuit 344 is provided to reset an address counter 307 within the microprocessor 300. The address counter 307 is incremented for each step processed to address the next word location within the memory 302. It has been found that noise such as generated by a defibrillation pulse or other source could affect the address counter 307 to address a meaningless or erroneous location within the memory 302. As a result the process would become "hung up- in a meaningless location. If the address would be affected by noise to address a meaningless location, the autoreset oscillator circuit 344 resets on a regular basis, e.g., 0.5 seconds, the address to an initial starting address of the program being executed. In the eventthatthe address counter 307 is operating normally, an output is derived from the data bus 310 and is applied via the conduit 346 to resetthe circuit 344, thus inhibiting its regular reset output signal.
In a further feature of this invention, the multip lexer 306 includes an additional set of inputs 339a to 339d for receiving a binary, starting address to be placed into the address counter 307, whereby each of the plurality of blocks 302-1 to 302-16 may be selected and executed. Thus, it is contemplated that' a plurality of heart pacing modes could be stored within the memory 302. with each mode stored in a separate block and its starting point could be addressed by entering a binary number via the inputs 339a to 339d and an external link 341 taking the form of an RF (or acoustical) link, as described above.
In addition, self-checking routines or data gathering routines may be stored within the blocks of the memory 302. In Figure 3A, there is shown an indica- tion of the manner in which an exemplary selfchecking routine could be carried out to testthe continuing operability of the ventricular sensing amplifier 139. A further select switch 130g may be closed in response to a test signal Tt that is generated by such a self-checking routine or program as stored within the memory 102, to apply a reference voltage V,f in the order of 1 millivolt to the input of the ventricular sensing amplifier 139. The amplified output is in turn applied by the multiplexer 106 to the mic- roprocessor 300, whereby the amplified voltage is compared with a reference value to determine whether the amplifier 139 is operative; if not, a different output circuit and sensing amplifier could be coupled in circuit to replace the defective sensing amplifier.
In a still further mode of operation, a program could be stored within one of the blocks of the memory 302 to effect a sensing and transmission of data as coupled by leads to the implanted pacemaker. For example, the leads could be coupled to hea rt tissue, other tissue or transducers, to sense the patient's EKG, pulse rate, pulse width, the time of depolarization between the atrium and ventricle, etc. The time. of transmission of a depolarization signal is consi-.
dered to be indicative of the heart's condition and az window is established by a sensing program in accordancewith a normal transmission time. If the received signal is outside the limits of such a window, an indication thereof is transmitted externally of the pacemaker. In a data gathering mode, it is contemplated that the latches associated with the associated leads to the heart sites, tissue sites, or transducers are coupled one at a time, by selectively closing the corresponding select switch 330, whereby that data is sent by the external link 341 to an external monitoring device.
In addition, there is included an input 338f coupled to the reed switch 23 of the type that is closed by an external magnet, to alter the operation of the pacemaker shown in Figure 7. It is contemplated that i GB 2 079 610 A 15 0 a succession of signals may be generated by opening and closing the switch 23, whereby the external link 341 is enabled to receive or to transmit data to or from the pacemaker 12% for example, the address counter 307 is loaded with a new address to address the starting location of the next block of memory 302, whereby a further mode of operation is executed.
Referring now to Figure 7A, there is shown a more detailed schematic circuit of the blocks of a first specific embodiment of the apparatus generally shown in Figure 6. In particular, the microprocessor 300 is identified illustratively as the COSMAC microprocessor as manufactured by the Radio Corpora- -15 tion of America and described in the publication enti- 80 tled "USER MANUAL FOR THE CDP 1802 COSMAC MICROPROCESSOR (1976)". The multiplexer306 has a series of sixteen inputs 0 to 15 and may take the form of the CDO067 as, manufactured by FICA to provide an output to the A/D converter 308. In turn, 85 the A/D converter 308.is coupled by the data bus 310 to the microprocessor 300, and is also connected to a latch 309, whereby one of the sixteen inputs of the multiplexer 306 is selected to apply analog data to the AJD converter 308. The N timing bus 352 is shown as a bundle of conduits 352a to d and is coupled to the decoder 342 made up of a plurality of gates as manufactured by RCA under a designation CD4012. The outputs of two of the gates are applied via the conduits 356 to a convert command input, whereby the A/D converter 308 accepts data from the multiplexer 306, and to a tristate output, whereby the A/D converter 308 is commanded to apply the data converted to digital form to the data buss 310.
Further, output strobes 1 and 2 are derived from conduits 354a and b, and applied respectively to latches 342a and 342b, whereby data applied to the data conduit 310 may be selectively applied to one of a plurality of switches contained within the blocks 330a and 330b, respectively. The blocks 330a and 330b each include four solid state select switches to provide output signals to selected output drive circuits. Further, in the particular embodiment shown in Figure 7A, the detected R wave signal is applied to the fF_1 input of the microprocessor 300, and the reed switch input is applied to the fF-2 input of the microprocessor 300. In this embodiment, the microprocessor 300 acts as its own multiplexerto selectively access and operate upon signals placed to these inputs in the desired sequence. Further, the microprocessor 300 applies addresses via the address bus 312 to the memory 302 whereby data may be read out and applied to the data bus 310.
In Figure 7B, there is shown a detailed schematic circuit of a further second embodiment of the pacemaker apparatus as shown generally in Figure 6. The elements in Figure 713 are numbered with the same number as like elements of Figure 6, except in the 500 series. The input signals corresponding to the R wave, the P wave and the reed switch output are applied to the inputs 1, t0_0 and tr-2 of the microprocessor 500, which may illustratively also take the form of the CDP 1802 microprocessor manufactured by RCA. In this embodiment, the microp65 rocessor500 performs multiplexing functions whereby one of these values is processed at a time. Typically such inputs are in analog form and require conversion to digital form by the circuits shown within the dotted lines marked generally by the numeral 508. The A/D converter includes a circuit as manufactured by RCA under their designation CD4508 and receives inputs from operational amplifiers 511 to which is applied a reference signal established by the Zener diodes 513. A clock signal is applied via a flip-flop 509 and an FET517 to an input of the converter 515. The system's memory 502 is connected to outputs of the microprocessor 500 and is comprised of two blocks manufactured by RCA under their designation CDP 1822S. The microprocessor 500 supplies command signals via the N bus 552 to a decoder 542 taking the form of a chip as manufactured by RCA under their designation CD 4514 B. The decoder 542 performs decoding functions on the output of the memory 502, under control of the timing signals applied via the N bus 552. The outputs of the decoder 542 are applied to a pair of latches 540a and 540b, each taking the form of the latch as manufactured by RCA undertheir designation CD4508. The decoder 542 selects a latch go whereby a corresponding select switch within the arrays 530a and 530b is closed. The arrays of select switches may be composed of integrated circuits as manufactured by RCA undertheir designation 4066AE.
Numerous changes may be made in the above described apparatus and the different embodiments of the invention may be made without departing from the scope thereof; therefore, it is intended that all matter contained in the foregoing description and in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense. CLAIMS 1. Body-implantableelectromedical apparatus including memory means for storing a program of instructions and a microprocessor for executing the program, the microprocessor including address means for addressing the memory, wherein there is included resetting means coupled to said microprocessor for periodically generating a reset signal to reset said address means to a predetermined return address, whereby if said address means inadvertentiy addresses a meaningless location in said memory means, the execution by said microprocessor of a selected program within said memory will be continued by addressing the predetermined return address within the selected program.
2. Apparatus as claimed in claim 1 wherein said microprocessor includes means coupled to said reset means for periodically generating and applying a defeat command signal to said reset means to defeat the operation of said reset means if said address means is operating correctly.
3. Body-implantable electromedical apparatus as claimed in claim 1 and substantially as hereinbefore described with reference to the accompanying drawings.
Printed for Her Majesty's Stationery Office by The Tweeddale Press Ltd.. Berwick-upon-Tweed, 1981. Published at the Patent Office, 25 Southampton Buildings, London, WC2A 1 AY, from which copies may be obtained.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92630378A | 1978-07-20 | 1978-07-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2079610A true GB2079610A (en) | 1982-01-27 |
GB2079610B GB2079610B (en) | 1983-04-07 |
Family
ID=25453021
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7925328A Expired GB2026870B (en) | 1978-07-20 | 1979-07-20 | Body-implantable pacemaker |
GB8127414A Expired GB2079610B (en) | 1978-07-20 | 1979-07-20 | Body-implantable electromedical apparatus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7925328A Expired GB2026870B (en) | 1978-07-20 | 1979-07-20 | Body-implantable pacemaker |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS5521990A (en) |
AU (2) | AU536053B2 (en) |
DE (2) | DE2929498A1 (en) |
FR (2) | FR2431296A1 (en) |
GB (2) | GB2026870B (en) |
IT (1) | IT1118131B (en) |
NL (1) | NL7905649A (en) |
SE (1) | SE445176B (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0087756A2 (en) * | 1982-02-26 | 1983-09-07 | Siemens Aktiengesellschaft | AV-sequential heart pacemaker |
EP0255899A1 (en) * | 1986-07-31 | 1988-02-17 | Werner Prof. Dr.-Ing. Irnich | Rate adaptive pacemaker |
WO1997043004A1 (en) * | 1996-05-16 | 1997-11-20 | Sulzer Intermedics Inc. | Programmably upgradable implantable medical device |
FR2772622A1 (en) * | 1997-12-23 | 1999-06-25 | Ela Medical Sa | ACTIVE CONFIGURABLE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERVER |
US7489561B2 (en) | 2005-10-24 | 2009-02-10 | Cyberonics, Inc. | Implantable medical device with reconfigurable non-volatile program |
US7711419B2 (en) | 2005-07-13 | 2010-05-04 | Cyberonics, Inc. | Neurostimulator with reduced size |
US7962220B2 (en) | 2006-04-28 | 2011-06-14 | Cyberonics, Inc. | Compensation reduction in tissue stimulation therapy |
US7996079B2 (en) | 2006-01-24 | 2011-08-09 | Cyberonics, Inc. | Input response override for an implantable medical device |
US8204603B2 (en) | 2008-04-25 | 2012-06-19 | Cyberonics, Inc. | Blocking exogenous action potentials by an implantable medical device |
US8260426B2 (en) | 2008-01-25 | 2012-09-04 | Cyberonics, Inc. | Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device |
US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
ITPI20130089A1 (en) * | 2013-10-16 | 2015-04-17 | Scuola Superiore Di Studi Universit Ari E Di Perfe | SYSTEM FOR MONITORING THE AGENT LOAD ON A PROSTHETIC SYSTEM. |
US9108041B2 (en) | 2006-03-29 | 2015-08-18 | Dignity Health | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US9314633B2 (en) | 2008-01-25 | 2016-04-19 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US9504390B2 (en) | 2011-03-04 | 2016-11-29 | Globalfoundries Inc. | Detecting, assessing and managing a risk of death in epilepsy |
US9700256B2 (en) | 2010-04-29 | 2017-07-11 | Cyberonics, Inc. | Algorithm for detecting a seizure from cardiac data |
US10220211B2 (en) | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
US10448839B2 (en) | 2012-04-23 | 2019-10-22 | Livanova Usa, Inc. | Methods, systems and apparatuses for detecting increased risk of sudden death |
US10653883B2 (en) | 2009-01-23 | 2020-05-19 | Livanova Usa, Inc. | Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation |
US11185695B1 (en) | 2003-11-26 | 2021-11-30 | Flint Hills Scientific, L.L.C. | Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7907462A (en) * | 1978-10-30 | 1980-05-02 | Medtronic Inc | PASSIONIST. |
US4230120A (en) * | 1978-11-06 | 1980-10-28 | Medtronic, Inc. | Energy compensation means for digital cardiac pacemaker |
EP0011935B2 (en) * | 1978-11-06 | 1991-05-22 | Medtronic, Inc. | Body stimulator programmer |
AU530108B2 (en) * | 1978-11-06 | 1983-06-30 | Medtronic, Inc. | Digital cardiac pacemaker |
US4273132A (en) * | 1978-11-06 | 1981-06-16 | Medtronic, Inc. | Digital cardiac pacemaker with threshold margin check |
US4295474A (en) * | 1979-10-02 | 1981-10-20 | The Johns Hopkins University | Recorder with patient alarm and service request systems suitable for use with automatic implantable defibrillator |
US4278094A (en) * | 1979-10-10 | 1981-07-14 | Medtronic, Inc. | Pacemaker with pulse width adjustment circuitry |
US4284082A (en) * | 1979-12-12 | 1981-08-18 | Medtronic B.V.Kerkrade | Ventricular synchronized atrial pacemaker and method of operation |
US4388927A (en) * | 1979-12-13 | 1983-06-21 | American Hospital Supply Corporation | Programmable digital cardiac pacer |
FR2471789A1 (en) * | 1979-12-18 | 1981-06-26 | Cardiofrance Co | MULTIPURPOSE IMPLANTABLE CARDIAC STIMULATOR AND METHOD OF USING THE STIMULATOR |
AU547290B2 (en) * | 1980-04-07 | 1985-10-17 | Medtronic, Inc. | Artifact rejection by demand pacemakers |
US4343311A (en) * | 1980-04-30 | 1982-08-10 | Medtronic, Inc. | Atrial refractory control for R-wave rejection in pacemakers |
DE3038856A1 (en) * | 1980-10-10 | 1982-05-27 | Siemens AG, 1000 Berlin und 8000 München | HEART PACEMAKER |
AU541479B2 (en) * | 1980-10-14 | 1985-01-10 | Medtronic, Inc. | Heart pacemeker with separate a-v intervals for a trial synchronous and atrial-ventricular sequential pacing modes |
DE3153780C2 (en) * | 1980-10-16 | 2003-04-03 | Ela Medical Sa | Implantable cardiac pacemaker control system |
FR2492552A1 (en) * | 1980-10-16 | 1982-04-23 | Ela Medical Sa | CONTROL DEVICE FOR AN IMPLANTABLE MEDICAL INSTRUMENT SUCH AS A HEART STIMULATOR AND HEART STIMULATOR COMPRISING THIS DEVICE |
FR2492262B1 (en) * | 1980-10-16 | 1987-02-20 | Ela Medical Sa | METHOD AND DEVICE FOR CONTROLLING AN APPARATUS OR INSTRUMENT, IN PARTICULAR AN IMPLANTABLE HEART STIMULATOR |
US4485818A (en) * | 1980-11-14 | 1984-12-04 | Cordis Corporation | Multi-mode microprocessor-based programmable cardiac pacer |
US4374382A (en) * | 1981-01-16 | 1983-02-15 | Medtronic, Inc. | Marker channel telemetry system for a medical device |
US4363325A (en) * | 1981-01-19 | 1982-12-14 | Medtronic, Inc. | Mode adaptive pacer |
EP0160801B1 (en) * | 1981-02-17 | 1991-09-25 | Medtronic, Inc. | Implantable medical device power source depletion indicators |
US4407288B1 (en) * | 1981-02-18 | 2000-09-19 | Mieczyslaw Mirowski | Implantable heart stimulator and stimulation method |
EP0077806B1 (en) * | 1981-05-04 | 1989-12-06 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Pacemaker |
WO1982003780A1 (en) * | 1981-05-04 | 1982-11-11 | Nettelhorst Herwig | Pacemaker |
EP0077808B1 (en) * | 1981-05-04 | 1987-08-26 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Pacemaker |
EP0077809B1 (en) * | 1981-05-04 | 1987-11-11 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Pacemaker |
EP0077801B1 (en) * | 1981-05-04 | 1987-09-23 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Pacemaker |
DE3278419D1 (en) * | 1981-05-04 | 1988-06-09 | Biotronik Mess & Therapieg | Cardiac pacemaker |
US4404972B1 (en) * | 1981-05-18 | 2000-07-11 | Intermedics Inc | Implantable device with microprocessor control |
US4390022A (en) * | 1981-05-18 | 1983-06-28 | Intermedics, Inc. | Implantable device with microprocessor control |
DE3127597A1 (en) * | 1981-07-13 | 1983-02-17 | Siemens AG, 1000 Berlin und 8000 München | METHOD AND PACEMAKER FOR BIFOCAL STIMULATION OF THE HEART |
US4561444A (en) * | 1981-08-10 | 1985-12-31 | Cordis Corporation | Implantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability |
DE3175940D1 (en) * | 1981-10-26 | 1987-04-09 | Vitafin Nv | Programmable cardiac pacemaker |
ATE25160T1 (en) * | 1981-10-26 | 1987-02-15 | Vitafin Nv | PACEMAKER USING DIRECT MEMORY ACCESS TO MICROPROCESSOR TO GENERATE OUTPUT PULSE SEQUENCES. |
AU1573183A (en) * | 1982-06-18 | 1983-12-22 | Biostim Inc. | Biological electrical stimulators |
US4562841A (en) * | 1982-08-05 | 1986-01-07 | Cardiac Pacemakers, Inc. | Programmable multi-mode cardiac pacemaker |
FR2533432A1 (en) * | 1982-09-23 | 1984-03-30 | Europ Propulsion | METHOD AND DEVICE FOR DETECTING THE HEART RESPONSE TO AN ELECTRIC STIMULUS PULSE |
US4467810A (en) * | 1982-09-30 | 1984-08-28 | Cordis Corporation | Multi-mode microprocessor-based programmable cardiac pacer |
US4558702A (en) * | 1983-01-21 | 1985-12-17 | Cordis Corporation | Cardiac pacer having input/output circuit programmable for use with unipolar and bipolar pacer leads |
US4665919A (en) * | 1983-03-14 | 1987-05-19 | Vitafin N.V. | Pacemaker with switchable circuits and method of operation of same |
FR2544988B1 (en) * | 1983-04-29 | 1986-10-10 | Ela Medical Sa | AURICULO-VENTRICULAR CARDIAC STIMULATOR |
US4549548A (en) * | 1983-09-14 | 1985-10-29 | Vitafin N.V. | Pacemaker system with automatic event-programmed switching between unipolar and bipolar operation |
US4577634A (en) * | 1983-11-22 | 1986-03-25 | Gessman Lawrence J | Method and apparatus for alleviating paroxysmal atrail tachycardia |
US4543963A (en) * | 1983-11-22 | 1985-10-01 | Gessman Lawrence J | Method and apparatus for differentiating antegrade from retrograde P-waves and for preventing pacemaker generated tachycardia |
US4559947A (en) * | 1984-01-27 | 1985-12-24 | Renger Herman L | Cardiac tissue stimulator providing P-wave verification, telemetry, marker channels, and antitachycardia capabilities |
EP0151689B1 (en) * | 1984-02-07 | 1990-12-27 | SCHIAPPARELLI MEDTRONIC S.p.A. | Minute ventilation dependent rate responsive pacer |
FR2561526A1 (en) * | 1984-03-22 | 1985-09-27 | Chaptal Paul | Cardiac stimulation method and cardiac stimulator for implementing the method |
US4585004A (en) * | 1984-06-01 | 1986-04-29 | Cardiac Control Systems, Inc. | Heart pacing and intracardiac electrogram monitoring system and associated method |
US4587970A (en) * | 1985-01-22 | 1986-05-13 | Telectronics N.V. | Tachycardia reversion pacer |
DE3689347D1 (en) * | 1985-09-17 | 1994-01-13 | Biotronik Mess & Therapieg | Pacemaker. |
DE3687388D1 (en) * | 1985-09-17 | 1993-02-11 | Biotronik Mess & Therapieg | HEART PACEMAKER. |
DE3687206D1 (en) * | 1985-09-17 | 1993-01-14 | Biotronik Mess & Therapieg | HEART PACEMAKER. |
EP0215730B1 (en) * | 1985-09-17 | 1993-06-16 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Heart stimulator |
US4803987A (en) * | 1986-06-11 | 1989-02-14 | Intermedics, Inc. | Temperature responsive controller for cardiac pacer |
FR2604908B1 (en) * | 1986-10-13 | 1990-06-22 | Saint Nicolas Cie Financiere | METHOD FOR ADJUSTING AN IMPLANTABLE HEART STIMULATOR ACCORDING TO THE EFFORT OF THE STIMULATOR CARRIER PATIENT, IMPLANTABLE HEART STIMULATOR AND EXTERNAL PROGRAMMER FOR CONTROLLING AN ADJUSTABLE IMPLANTABLE HEART STIMULATOR |
EP0444021B1 (en) * | 1987-11-13 | 1995-01-25 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Cardiac pacemaker |
AU614118B2 (en) * | 1988-04-19 | 1991-08-22 | Pacesetter Ab | Configuration programming of an implantable pacemaker |
US4899750A (en) * | 1988-04-19 | 1990-02-13 | Siemens-Pacesetter, Inc. | Lead impedance scanning system for pacemakers |
EP0387363B1 (en) * | 1989-03-13 | 1994-06-01 | Pacesetter AB | Implantable stimulator whose intensity of stimulation of a physiologic event of living beings is adapted to their physical actvity |
US5031616A (en) * | 1989-12-07 | 1991-07-16 | Siemens-Pacesetter, Inc. | Implantable stimulation device having means for self-regulating curent drain usage at battery depletion |
US5058581A (en) * | 1990-02-20 | 1991-10-22 | Siemens-Pacesetter, Inc. | Telemetry apparatus and method for implantable tissue stimulator |
US5052389A (en) * | 1990-07-26 | 1991-10-01 | Cook Pacemaker Corporation | Low-power A/D converter for an implantable medical device and method of use |
DE4339304B4 (en) * | 1993-11-18 | 2005-09-15 | Robert Bosch Gmbh | Circuit arrangement with a transmission element |
SE9602846D0 (en) * | 1996-07-23 | 1996-07-23 | Pacesetter Ab | A stimulation device |
DE19724053A1 (en) * | 1997-06-07 | 1998-12-10 | Biotronik Mess & Therapieg | Electronic storage device, in particular for use in implantable medical devices |
DE102004019391A1 (en) * | 2004-04-19 | 2005-11-03 | Endress + Hauser Gmbh + Co. Kg | Parameterizable electronic device |
US8565867B2 (en) | 2005-01-28 | 2013-10-22 | Cyberonics, Inc. | Changeable electrode polarity stimulation by an implantable medical device |
US8700163B2 (en) | 2005-03-04 | 2014-04-15 | Cyberonics, Inc. | Cranial nerve stimulation for treatment of substance addiction |
US7840280B2 (en) | 2005-07-27 | 2010-11-23 | Cyberonics, Inc. | Cranial nerve stimulation to treat a vocal cord disorder |
US7869885B2 (en) | 2006-04-28 | 2011-01-11 | Cyberonics, Inc | Threshold optimization for tissue stimulation therapy |
US7869867B2 (en) | 2006-10-27 | 2011-01-11 | Cyberonics, Inc. | Implantable neurostimulator with refractory stimulation |
US7974701B2 (en) | 2007-04-27 | 2011-07-05 | Cyberonics, Inc. | Dosing limitation for an implantable medical device |
US8382667B2 (en) | 2010-10-01 | 2013-02-26 | Flint Hills Scientific, Llc | Detecting, quantifying, and/or classifying seizures using multimodal data |
US8337404B2 (en) | 2010-10-01 | 2012-12-25 | Flint Hills Scientific, Llc | Detecting, quantifying, and/or classifying seizures using multimodal data |
US8571643B2 (en) | 2010-09-16 | 2013-10-29 | Flint Hills Scientific, Llc | Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex |
US8417344B2 (en) | 2008-10-24 | 2013-04-09 | Cyberonics, Inc. | Dynamic cranial nerve stimulation based on brain state determination from cardiac data |
US8827912B2 (en) | 2009-04-24 | 2014-09-09 | Cyberonics, Inc. | Methods and systems for detecting epileptic events using NNXX, optionally with nonlinear analysis parameters |
US8239028B2 (en) | 2009-04-24 | 2012-08-07 | Cyberonics, Inc. | Use of cardiac parameters in methods and systems for treating a chronic medical condition |
US8649871B2 (en) | 2010-04-29 | 2014-02-11 | Cyberonics, Inc. | Validity test adaptive constraint modification for cardiac data used for detection of state changes |
US8831732B2 (en) | 2010-04-29 | 2014-09-09 | Cyberonics, Inc. | Method, apparatus and system for validating and quantifying cardiac beat data quality |
US8679009B2 (en) | 2010-06-15 | 2014-03-25 | Flint Hills Scientific, Llc | Systems approach to comorbidity assessment |
US8641646B2 (en) | 2010-07-30 | 2014-02-04 | Cyberonics, Inc. | Seizure detection using coordinate data |
US8684921B2 (en) | 2010-10-01 | 2014-04-01 | Flint Hills Scientific Llc | Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis |
US9498162B2 (en) | 2011-04-25 | 2016-11-22 | Cyberonics, Inc. | Identifying seizures using heart data from two or more windows |
US9402550B2 (en) | 2011-04-29 | 2016-08-02 | Cybertronics, Inc. | Dynamic heart rate threshold for neurological event detection |
CN109011152B (en) * | 2018-08-22 | 2022-03-18 | 创领心律管理医疗器械(上海)有限公司 | Fixing device, testing device and testing method for pacemaker in-vitro test |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3668690A (en) | 1970-06-08 | 1972-06-06 | Ormond Alfred N | Method and apparatus for analog to digital conversion |
US3825015A (en) * | 1972-12-14 | 1974-07-23 | American Optical Corp | Single catheter for atrial and ventricular stimulation |
DE2427800A1 (en) | 1973-06-11 | 1975-02-20 | Gen Electric | ANALOG-DIGITAL CONVERTER |
NL7700427A (en) * | 1976-03-03 | 1977-09-06 | Arco Med Prod Co | PLANTABLE DIGITAL PASSENGER WHICH IS FITTED WITH EXTERNALLY SELECTABLE BUSINESS PARAMETERS. |
DE2738871A1 (en) * | 1976-09-29 | 1978-03-30 | Arco Med Prod Co | PACEMAKER |
NL7713772A (en) * | 1976-12-14 | 1978-06-16 | American Hospital Supply Corp | HEART STIMULATOR. |
US4232679A (en) * | 1977-01-26 | 1980-11-11 | Pacesetter Systems, Inc. | Programmable human tissue stimulator |
DE2861544D1 (en) * | 1977-08-19 | 1982-03-04 | Biotronik Mess & Therapieg | Demand pacer with programmable rate hysteresis |
DE2861717D1 (en) * | 1977-08-19 | 1982-05-19 | Biotronik Mess & Therapieg | Programmer for implanted pacer |
EP0001156B1 (en) * | 1977-08-19 | 1983-05-11 | BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin | Programmable, implantable body function control apparatus and method for reprogramming said apparatus |
-
1979
- 1979-07-16 IT IT49768/79A patent/IT1118131B/en active
- 1979-07-17 AU AU48989/79A patent/AU536053B2/en not_active Expired
- 1979-07-18 FR FR7918562A patent/FR2431296A1/en active Granted
- 1979-07-19 JP JP9209879A patent/JPS5521990A/en active Granted
- 1979-07-19 SE SE7906205A patent/SE445176B/en unknown
- 1979-07-20 DE DE19792929498 patent/DE2929498A1/en active Granted
- 1979-07-20 NL NL7905649A patent/NL7905649A/en not_active Application Discontinuation
- 1979-07-20 GB GB7925328A patent/GB2026870B/en not_active Expired
- 1979-07-20 GB GB8127414A patent/GB2079610B/en not_active Expired
- 1979-07-20 DE DE2954642A patent/DE2954642C2/de not_active Expired - Lifetime
-
1980
- 1980-03-27 FR FR8006814A patent/FR2445659B1/en not_active Expired
-
1984
- 1984-09-04 AU AU32713/84A patent/AU584310B2/en not_active Expired
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0087756A2 (en) * | 1982-02-26 | 1983-09-07 | Siemens Aktiengesellschaft | AV-sequential heart pacemaker |
EP0087756A3 (en) * | 1982-02-26 | 1986-03-12 | Siemens Aktiengesellschaft | Av-sequential heart pacemaker |
EP0255899A1 (en) * | 1986-07-31 | 1988-02-17 | Werner Prof. Dr.-Ing. Irnich | Rate adaptive pacemaker |
US6073049A (en) * | 1996-05-16 | 2000-06-06 | Sulzer Intermedics, Inc. | Programmably upgradable implantable cardiac pacemaker |
WO1997043004A1 (en) * | 1996-05-16 | 1997-11-20 | Sulzer Intermedics Inc. | Programmably upgradable implantable medical device |
FR2772622A1 (en) * | 1997-12-23 | 1999-06-25 | Ela Medical Sa | ACTIVE CONFIGURABLE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR CARDIAC STIMULATOR, DEFIBRILLATOR AND / OR CARDIOVERVER |
EP0925806A1 (en) * | 1997-12-23 | 1999-06-30 | ELA MEDICAL (Société anonyme) | Configurable multisite implantable active medical device, especially heart stimulator, defibrillator and/or cardioverter |
US6253106B1 (en) | 1997-12-23 | 2001-06-26 | Ela Medical S.A. | Configurable multisite active implantable medical device |
US11185695B1 (en) | 2003-11-26 | 2021-11-30 | Flint Hills Scientific, L.L.C. | Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals |
US9586047B2 (en) | 2005-01-28 | 2017-03-07 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US7711419B2 (en) | 2005-07-13 | 2010-05-04 | Cyberonics, Inc. | Neurostimulator with reduced size |
US7489561B2 (en) | 2005-10-24 | 2009-02-10 | Cyberonics, Inc. | Implantable medical device with reconfigurable non-volatile program |
US7996079B2 (en) | 2006-01-24 | 2011-08-09 | Cyberonics, Inc. | Input response override for an implantable medical device |
US9533151B2 (en) | 2006-03-29 | 2017-01-03 | Dignity Health | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US9108041B2 (en) | 2006-03-29 | 2015-08-18 | Dignity Health | Microburst electrical stimulation of cranial nerves for the treatment of medical conditions |
US9289599B2 (en) | 2006-03-29 | 2016-03-22 | Dignity Health | Vagus nerve stimulation method |
US7962220B2 (en) | 2006-04-28 | 2011-06-14 | Cyberonics, Inc. | Compensation reduction in tissue stimulation therapy |
US9314633B2 (en) | 2008-01-25 | 2016-04-19 | Cyberonics, Inc. | Contingent cardio-protection for epilepsy patients |
US8260426B2 (en) | 2008-01-25 | 2012-09-04 | Cyberonics, Inc. | Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device |
US8204603B2 (en) | 2008-04-25 | 2012-06-19 | Cyberonics, Inc. | Blocking exogenous action potentials by an implantable medical device |
US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
US8874218B2 (en) | 2008-10-20 | 2014-10-28 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
US10653883B2 (en) | 2009-01-23 | 2020-05-19 | Livanova Usa, Inc. | Implantable medical device for providing chronic condition therapy and acute condition therapy using vagus nerve stimulation |
US9700256B2 (en) | 2010-04-29 | 2017-07-11 | Cyberonics, Inc. | Algorithm for detecting a seizure from cardiac data |
US9504390B2 (en) | 2011-03-04 | 2016-11-29 | Globalfoundries Inc. | Detecting, assessing and managing a risk of death in epilepsy |
US10448839B2 (en) | 2012-04-23 | 2019-10-22 | Livanova Usa, Inc. | Methods, systems and apparatuses for detecting increased risk of sudden death |
US11596314B2 (en) | 2012-04-23 | 2023-03-07 | Livanova Usa, Inc. | Methods, systems and apparatuses for detecting increased risk of sudden death |
US10220211B2 (en) | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
US11103707B2 (en) | 2013-01-22 | 2021-08-31 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
ITPI20130089A1 (en) * | 2013-10-16 | 2015-04-17 | Scuola Superiore Di Studi Universit Ari E Di Perfe | SYSTEM FOR MONITORING THE AGENT LOAD ON A PROSTHETIC SYSTEM. |
Also Published As
Publication number | Publication date |
---|---|
FR2431296A1 (en) | 1980-02-15 |
AU536053B2 (en) | 1984-04-19 |
AU3271384A (en) | 1984-12-20 |
DE2954642C2 (en) | 1991-11-07 |
NL7905649A (en) | 1980-01-22 |
SE445176B (en) | 1986-06-09 |
DE2929498A1 (en) | 1980-01-31 |
AU584310B2 (en) | 1989-05-25 |
JPS6241032B2 (en) | 1987-09-01 |
DE2929498C2 (en) | 1991-07-11 |
FR2431296B1 (en) | 1984-01-06 |
GB2079610B (en) | 1983-04-07 |
GB2026870B (en) | 1982-12-15 |
IT7949768A0 (en) | 1979-07-16 |
IT1118131B (en) | 1986-02-24 |
JPS5521990A (en) | 1980-02-16 |
SE7906205L (en) | 1980-01-21 |
AU4898979A (en) | 1980-01-24 |
FR2445659A1 (en) | 1980-07-25 |
FR2445659B1 (en) | 1985-11-29 |
GB2026870A (en) | 1980-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2079610A (en) | Body-implantable electromedical apparatus | |
US5318593A (en) | Multi-mode adaptable implantable pacemaker | |
US5766229A (en) | Capture verification method and apparatus for implantable pacemaker utilizing heart rhythm stability measurements to minimize the likelihood of fusion | |
US4208008A (en) | Pacing generator programming apparatus including error detecting means | |
US5944745A (en) | Implantable medical device capable of prioritizing diagnostic data and allocating memory for same | |
US4485818A (en) | Multi-mode microprocessor-based programmable cardiac pacer | |
US8204594B2 (en) | Cardiac rhythm management system and method | |
US6622045B2 (en) | System and method for remote programming of implantable cardiac stimulation devices | |
US4236524A (en) | Program testing apparatus | |
US5534018A (en) | Automatic lead recognition for implantable medical device | |
US4606349A (en) | Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability | |
US6687543B1 (en) | Implantable cardiac stimulation device having reduced shelf current consumption and method | |
US5159926A (en) | Medical stimulation and/or monitoring device interacting with the body of a patient based upon selectable parameter set | |
EP1594568B1 (en) | Impedance measurement in implanted device | |
US7676272B2 (en) | Implantable device system to collect parameter data for service center | |
US5092330A (en) | Analog to digital converter | |
US3757792A (en) | Automatic threshold compensating demand pacemaker | |
US6658283B1 (en) | Implantable cardiac stimulation device, system and method which provides an electrogram signal having the appearance of a surface electrocardiogram | |
US4305397A (en) | Pacing generator programmer with transmission checking circuit | |
US4561444A (en) | Implantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability | |
US6650937B2 (en) | Method and system for gradual cardiac training using an implantable medical device | |
Beyersdorf et al. | Increase in cardiac output with rate-responsive pacemaker | |
US6748268B1 (en) | Three lead universal pacing and shocking system | |
US6694179B1 (en) | Display for and method of displaying electrograms received from an implantable cardiac stimulation device | |
BAROLD et al. | Inappropriate Slowing of the Pacemaker Rate with Programmahle Demand Pacemaker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930720 |